Drug: CISPLATIN. Injury: Disease progression Quarter: 2016Q3
Total Records: 50 Number of Pages: 3
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
125930282 | CISPLATIN. | Disease progression | TEVA | 0.00 | M | 0 | 20160811 | GB |
126096552 | CISPLATIN. | Disease progression | ACCORD | 0.00 | M | 0 | 20160806 | GB |
126137102 | CISPLATIN. | Disease progression | PIERRE FABRE MEDICAMENT | 0.00 | M | 0 | 20160810 | GB |
126296132 | CISPLATIN. | Disease progression | TEVA | 0.00 | F | 0 | 20160825 | GB |
126302631 | CISPLATIN. | Disease progression | AVENTIS | 0.00 | F | 48 KG | 20160808 | JP |
126406134 | CISPLATIN. | Disease progression | PFIZER | 0.00 | F | 0 | 20160902 | GB |
126438742 | CISPLATIN. | Disease progression | CONCORDIA | 0.00 | F | 0 | 20160822 | GB |
126482311 | CISPLATIN. | Disease progression | AVENTIS | 59.00 YR | M | 0 | 20160812 | CN |
126487362 | CISPLATIN. | Disease progression | JANSSEN | 0.00 | F | 0 | 20160816 | GB |
126516702 | CISPLATIN. | Disease progression | PFIZER | 0.00 | F | 0 | 20160829 | GB |
126532702 | CISPLATIN. | Disease progression | BAUSCH AND LOMB | 0.00 | F | 0 | 20160816 | GB |
126628233 | CISPLATIN. | Disease progression | PFIZER | 62.00 YR | F | 0 | 20160901 | GB |
126746921 | CISPLATIN. | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN | |
126748771 | CISPLATIN. | Disease progression | CIPLA | 0.00 | 0 | 20160823 | CN | |
126754753 | CISPLATIN. | Disease progression | ACCORD | 0.00 | F | 0 | 20160906 | GB |
126789751 | CISPLATIN. | Disease progression | CIPLA | 0.00 | 0 | 20160824 | US | |
126825121 | CISPLATIN. | Disease progression | CIPLA | 0.00 | 0 | 20160825 | CN | |
126838142 | CISPLATIN. | Disease progression | CONCORDIA | 62.00 YR | F | 0 | 20160826 | GB |
126932131 | CISPLATIN. | Disease progression | CIPLA | 0.00 | 0 | 20160829 | JP | |
126938041 | CISPLATIN. | Disease progression | PFIZER | 36.00 YR | F | 0 | 20160829 | US |
Total Records: 50 Number of Pages: 3